Mounjaro®
Starting from £179.99/mo
Start journey Learn moreConstipation is one of the more stubborn side effects that comes with tirzepatide, and knowing which laxative to reach for matters. The short answer: an osmotic laxative such as macrogol (Movicol, Laxido) is generally the first choice, with bulk-forming agents like ispaghula husk a close second — both are well-tolerated and avoid the griping that stimulant laxatives can cause. Constipation linked to Mounjaro happens because tirzepatide slows gastric emptying as part of how it works; that slowdown extends into the lower gut for some people. It is listed as a common side effect on the NHS tirzepatide medicines page, typically settling within a few weeks. These are prescription-only medicines, so any concern about managing side effects is best discussed with a prescriber, who can weigh your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
A question our prescribers hear most weeks is whether it is safe to take a laxative alongside Mounjaro. The straightforward answer is yes, for the types most commonly recommended. Osmotic laxatives (macrogol being the main one sold as Movicol or Laxido) work by drawing water into the bowel, softening the stool rather than forcing a contraction. That mechanism fits well with tirzepatide-related constipation, which tends to be about transit slowdown rather than hard stools alone.
Lactulose is another osmotic option, available without prescription, though it can cause bloating in some people and takes longer to act than macrogol. For those who prefer a non-medicated route first, bulk-forming agents like ispaghula husk (Fybogel) add fibre that retains water in the gut, but they need to be taken with a full glass of water, and fluid intake generally needs to be adequate for them to help rather than hinder. You can read more about the constipation pattern specific to tirzepatide on our Mounjaro constipation overview.
Docusate sodium sits in a slightly different category (a stool softener rather than a true laxative) and can be combined with the above if stools remain hard. It is widely available, generally well-tolerated, and does not carry the cramping risk of stimulant types.
Stimulant laxatives, such as senna or bisacodyl, prompt the gut muscle to contract. They work, but the contraction can be uncomfortable, particularly on a gut that is already adjusting to slower motility from tirzepatide. They are not the first choice here. Prolonged or frequent use of stimulant laxatives is also associated with bowel dependence, so they are best kept for occasions when other approaches have not moved things along after a couple of days.
If you do use one, a short course is sensible. The concern is not a dangerous drug interaction (there is no direct pharmacological clash between senna and tirzepatide) but comfort and longer-term bowel habits are worth protecting. Our page on what to take for constipation on Mounjaro covers these options in more detail, including practical notes on timing and dose.
Suppositories and enemas are occasionally used when oral laxatives have not worked, but they are better discussed with a pharmacist or GP before use, particularly if constipation has been present for more than a week.
No laxative works as well as it should when someone is significantly under-hydrated. Tirzepatide reduces appetite and, for some people, fluid intake dips along with food intake. Aiming for roughly 1.5–2 litres of water or non-caffeinated fluid daily gives an osmotic laxative something to work with. Caffeinated drinks count toward fluid intake but can have a mild dehydrating effect in excess, so plain water or herbal teas are better choices when constipation is active.
Dietary fibre from vegetables, legumes and whole grains adds bulk that keeps transit moving, and gentle physical activity (even a twenty-minute walk) supports gut motility. These measures are not a replacement for a laxative when constipation is established, but they reduce the chance of it recurring. Our guide to stopping constipation on Mounjaro covers the dietary and lifestyle side in more detail.
One note on fibre supplements: if ispaghula husk is taken without enough fluid, it can sit in the gut and worsen blockage rather than ease it. That is not a common problem, but it is worth knowing before reaching for a bulk-forming product.
Mild constipation that improves within a week or two with laxatives and hydration is the typical pattern. It is worth seeking medical advice sooner if you experience severe or worsening abdominal pain, vomiting, bloating that does not settle, or no bowel movement for more than five days despite laxative use, and if you are wondering whether Mounjaro can give you constipation in the first place, that question is covered in its own dedicated page. These could indicate something beyond slow transit that needs assessment.
Separately, the MHRA issued a Drug Safety Update in January 2026 highlighting acute pancreatitis as a known, though infrequent, side effect of GLP-1 medicines. Severe stomach pain that radiates toward the back (with or without vomiting) is distinct from ordinary constipation discomfort and warrants urgent medical attention rather than a laxative. You can report any suspected side effect through the MHRA Yellow Card scheme, which accepts reports from patients directly.
For the wider picture of what Mounjaro can cause and how common each effect is, the full side effects page is a useful reference. If constipation is affecting your quality of life or confidence in staying on treatment, our prescribers discuss exactly this as part of the consultation, and can advise on whether any adjustment is warranted. Speak to our prescribers through a free consultation if that would help.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.